pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    AK-antiVEGF
    Vestibular Schwannoma (Acoustic Neuroma) Eli Lilly and Co
  • Preclinical
    AKT-001
    Acute Respiratory Distress Syndrome Akttyva Therapeutics Inc
  • Preclinical
    AKT-103
    Nephrotic Syndrome ArKri Therapeutics
  • Preclinical
← prev
page 51 of 231
next →
131
Pain89
Neurology1
AKT-105
Esophageal Cancer
ArKri Therapeutics
  • Preclinical
    AKT-107
    Bullous Pemphigoid ArKri Therapeutics
  • Phase 1
    AKY-1189
    Cervical Cancer$AKTS Aktis Oncology, Inc.
  • Phase 2
    AL-001
    LiProSal
    Bipolar Disorder (Manic Depression)$ALZN Alzamend Neuro, Inc.
  • Preclinical
    AL-002
    Neurodegenerative Diseases$ALZN Alzamend Neuro, Inc.
  • Phase 1
    ALA-002
    Social Anxiety Disorder (SAD/Social Phobia) PharmAla Biotech Inc
  • Preclinical
    ALC-919
    Alzheimer's Disease Hokkaido University
  • Phase 2
    ALEP-02
    Cervical Cancer Alentis Therapeutics AG
  • Phase 2
    ALG-009
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or…$ALGS Aligos Therapeutics, Inc.
  • Phase 2
    ALG.APV-527
    Cervical Cancer Alligator Bioscience AB
  • ALISKIREN
    ALISKIREN (ALISKIREN HEMIFUMARATE)
    no indication LXO IRELAND
  • Preclinical
    ALL-027
    Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) Phoenix Nest Inc
  • ALLEGRA-D ALLERGY AND CONGESTION
    ALLEGRA-D ALLERGY AND CONGESTION (FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE)
    no indication CHATTEM SANOFI
  • ALLERGY CONGESTION RELIEF
    ALLERGY CONGESTION RELIEF (LORATADINE, PSEUDOEPHEDRINE SULFATE)
    no indication PERRIGO PHARMA INTL
  • ALLERGY RELIEF
    ALLERGY RELIEF (CETIRIZINE HCL)
    no indication ONESOURCE SPECIALTY
  • ALLERGY RELIEF-D
    ALLERGY RELIEF-D (LORATADINE AND PSEUDOEPHEDRINE SULFATE)
    no indication BIONPHARMA
  • Phase 1
    ALLO-316
    Metastatic Renal Cell Carcinoma$ALLO Allogene Therapeutics, Inc.
  • Phase 1
    ALLO-329
    Lupus Nephritis$ALLO Allogene Therapeutics, Inc.
  • pre_registration
    ALM-003
    Depression Almatica Pharma LLC
  • Phase 1
    ALM-412
    Dystrophic Epidermolysis Bullosa Almirall SA
  • ALOCRIL
    ALOCRIL (NEDOCROMIL SODIUM)
    no indication ALLERGAN
  • ALOGLIPTIN AND PIOGLITAZONE
    ALOGLIPTIN AND PIOGLITAZONE (ALOGLIPTIN BENZOATE AND PIOGLITAZONE HYDROCHLORIDE)
    no indication TAKEDA PHARMS USA
  • Phase 1
    ALX-001
    Alzheimer's Disease Allyx Therapeutics Inc
  • Phase 1
    ALX-1
    Bronchiectasis Vast Therapeutics Inc
  • Phase 1
    ALX-2004
    Colorectal Cancer$ALXO ALX ONCOLOGY HOLDINGS INC
  • Phase 2
    ALY-101
    Alopecia Areata Alys Pharmaceuticals Inc
  • Preclinical
    ALY-732
    Duchenne Muscular Dystrophy Allysta Pharmaceuticals Inc